NRx Pharmaceuticals (NASDAQ:NRXP) on Monday reported the minutes of a Type B meeting with the U.S. Food and Drug Administration's (FDA) Division of Psychiatry Products held on Jan. 11 linked to filing ...

Developing Therapeutics for the Treatment of CNS Disorders, Specifically Suicidal Bipolar Depression, Chronic Pain and PTSD. Alignment on Initial Pediatric Study Plan is a Gating Requirement for ...

From brain scans revealing medication’s effects to AI-powered detection using lab models, here are 5 new developments in bipolar disorder research. When you live with bipolar disorder, you’re like ...

This common dual diagnosis — bipolar disorder and substance use disorder — calls for treatment that addresses both challenges. At one time, Joanne M. found herself tangled in a web of a mental health ...